Edition:
India

InterCure Ltd (INCR.TA)

INCR.TA on Tel Aviv Stock Exchange

1,081.00ILa
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
1,081.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,709,124
52-wk High
1,420.00
52-wk Low
34.20

About

InterCure Ltd is an Israel-based medical device company. It is engaged in the production and sale of RESPeRATE, a Food and Drug Administration approved, non-drug, non-invasive hypertension treatment device. The Company’s patented device-guided breathing platform is used by RESPeRATE, and it enables a systematic reduction in... (more)
No analyst recommendations are available for .

Overall

Beta: -0.16
Market Cap(Mil.): ₪1,088.63
Shares Outstanding(Mil.): 105.31
Dividend: --
Yield (%): --

Financials

RPT-Israel likely to allow medical cannabis exports by year-end - senior MP

JERUSALEM, Dec 6 Israel will likely allow exports of medical cannabis by the end of the year, a top lawmaker said on Thursday, a move that would boost state coffers and slow the growing number of firms establishing farms abroad.

11 Dec 2018

Israeli medical cannabis firm InterCure plans Nasdaq listing

JERUSALEM Israel's InterCure , which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.

06 Dec 2018

Israeli medical cannabis firm InterCure plans Nasdaq listing

JERUSALEM, Dec 6 Israel's InterCure, which recently entered the medical cannabis market, plans to list on Nasdaq by mid-2019, its controlling shareholder, Alex Rabinovitch, said on Thursday.

06 Dec 2018

Earnings vs. Estimates

No consensus analysis data available.